HER-2 Positive Breast Cancer Active Not Recruiting Phase 2 Trials for Trastuzumab emtansine (DB05773)

IndicationStatusPhase
DBCOND0042425 (HER-2 Positive Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02326974T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCATreatment
NCT01565200HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1Diagnostic